Researchers warn that the public, policy makers and even clinicians are not aware of the growing problem of liver cancer.

Liver cancer is still relatively rare in the United States, representing 2.1% of all new cancer diagnoses in 2025. The report ...

At least 60% of liver cancers globally are preventable through risk-factor reduction, including obesity-linked metabolic ...

The majority of liver cancer cases could be prevented by reducing levels of viral hepatitis, alcohol consumption and MASLD ...

Certain foods and nutrients were found to influence the risk of developing liver cancer. For example, aflatoxins (toxins from ...

The majority of liver cancer cases could be prevented by reducing levels of viral hepatitis, alcohol consumption and MASLD ...

Without efforts to address some causes, including alcohol use and metabolic issues, the researchers warn that cases could ...

Poor dietary habits and obesity are key contributors to non-alcoholic fatty liver disease (NAFLD).leading to inflammation and ...

Advances such as triple agonists, gene editing, and microbiome therapy offer hope for metabolic diseases, but global access and early detection remain limited.

MASLD is highly prevalent among individuals with chronic hepatitis B and increases the risk for liver fibrosis.

Imagine a future where the global incident cases of liver cancer almost doubles, rising from 870 000 cases in 2022 to over ...

“It is one of the most challenging cancers to treat, with five-year survival rates ranging from approximately 5% to 30%,” ...